Preferred Name | salmeterol | |
Synonyms |
(+-)-4-hydroxy-alpha(1)-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-m-xylene-alpha,alpha(1)-diol (+-)-salmeterol (RS)-4-hydroxy-alpha(1)-({[6-(4-phenylbutoxy)hexyl]amino}methyl)-1,3-benzenedimethanol (RS)-salmeterol salmeterolum salmeterol Salmeterol |
|
Definitions |
A racemate consisting of equal parts of (R)- and (S)-salmeterol. It is a potent and selective beta2-adrenoceptor agonist (EC50 = 5.3 nM). Unlike other beta2 agonists, it binds to the exo-site domain of beta2 receptors, producing a slow onset of action and prolonged activation. |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_9011 |
|
charge |
0 |
|
database_cross_reference |
KEGG:C07241 NCIt:C29443 CiteXplore:22192967 CiteXplore:22245487 PMID:22192967 MeSH:C057823 KEGG:D05792 SNOMEDCT:372515005 Wikipedia:Salmeterol CiteXplore:22231554 KEGG COMPOUND:C07241 SNOMEDCT:108605008 ChemIDplus:89365-50-4 PMID:22235841 PMID:22231554 CiteXplore:22235841 DrugBank:DB00938 PMID:22245487 HMDB:HMDB0015073 Patent:DE3414752 KEGG COMPOUND:89365-50-4 CAS:89365-50-4 KEGG DRUG:D05792 Patent:US4992474 |
|
definition |
A racemate consisting of equal parts of (R)- and (S)-salmeterol. It is a potent and selective beta2-adrenoceptor agonist (EC50 = 5.3 nM). Unlike other beta2 agonists, it binds to the exo-site domain of beta2 receptors, producing a slow onset of action and prolonged activation. |
|
formula |
C25H37NO4 |
|
has characteristic | ||
has_exact_synonym |
Salmeterol |
|
has_obo_namespace |
chebi_ontology |
|
has_related_synonym |
(+-)-4-hydroxy-alpha(1)-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-m-xylene-alpha,alpha(1)-diol (+-)-salmeterol (RS)-4-hydroxy-alpha(1)-({[6-(4-phenylbutoxy)hexyl]amino}methyl)-1,3-benzenedimethanol (RS)-salmeterol salmeterolum salmeterol |
|
has_role | ||
id |
CHEBI:9011 |
|
in_subset | ||
label |
salmeterol |
|
mass |
415.56560 |
|
monoisotopicmass |
415.27226 |
|
notation |
CHEBI:9011 |
|
preferred label |
salmeterol |
|
prefLabel |
salmeterol |
|
subClassOf |